1. Chang K, Ahn Y, Lim S, et al. 2021 Korean Society of Myocardial Infarction Expert Consensus document on revascularization for acute myocardial infarction. Korean Circ J. 2021; 51:289–307. PMID:
33821579.
2. Jung Y, Kim J, Jang H, Kim G, Kwon YW. Strategy of patient-specific therapeutics in cardiovascular disease through single-cell RNA sequencing. Korean Circ J. 2023; 53:1–16. PMID:
36627736.
3. Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016; 26:165–176. PMID:
26653790.
4. Li J, Cao F, Yin HL, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020; 11:88. PMID:
32015325.
5. Song Y, Wang B, Zhu X, et al. Human umbilical cord blood-derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice. Cell Biol Toxicol. 2021; 37:51–64. PMID:
32535745.
6. Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021; 22:96–118. PMID:
33353982.
7. Dai R, Yang X, He W, Su Q, Deng X, Li J. LncRNA AC005332.7 inhibited ferroptosis to alleviate acute myocardial infarction through regulating miR-331-3p/CCND2 axis. Korean Circ J. 2023; 53:151–167.
8. Toischer K, Zhu W, Hünlich M, et al. Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload. J Clin Invest. 2017; 127:4285–4296. PMID:
29083322.
9. Zhu W, Zhao M, Mattapally S, Chen S, Zhang J. CCND2 overexpression enhances the regenerative potency of human induced pluripotent stem cell-derived cardiomyocytes: remuscularization of injured ventricle. Circ Res. 2018; 122:88–96. PMID:
29018036.